Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase replacements are therapeutic preparations containing the enzyme lipase, often combined with amylase and protease, used to treat exocrine pancreatic insufficiency (EPI). These enzymes aid in the digestion of fats, improving nutrient absorption and alleviating symptoms like steatorrhea. Current formulations are primarily derived from porcine sources, with non-animal alternatives under development. Dosing is individualized based on patient weight, age, and dietary fat content.
Hydrolyzes dietary triglycerides into absorbable free fatty acids and monoglycerides within the small intestine, compensating for insufficient endogenous enzyme secretion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase Replacements (PERT).